ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,431.60
      -0.04%
      US Tech 100
      19,167.60
      0.00%
      Dow Jones
      38,589.16
      -0.15%
      Brent Oil
      82.105
      -0.02%
      Bitcoin
      65,911.21
      -1.10%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Scilex Holding Company (SCLX)

      7. Scilex Holding Company (SCLX) News

      SCLX

      Scilex (SCLX)

      Scilex Holding Company
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:SCLX
      DateTimeSourceHeadlineSymbolCompany
      06/14/20241:41PMGlobeNewswire Inc.Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)NASDAQ:SCLXScilex Holding Company
      06/13/20249:00AMGlobeNewswire Inc.Scilex Holding Company to Present Poster on ELYXYB® (celecoxib oral solution) at the 66th Annual Scientific Meeting of the American Headache Society (AHS) to be Held in San Diego, CA on June 13-16, 2024NASDAQ:SCLXScilex Holding Company
      06/12/20243:37PMAllPennyStocks.comPharma Shares Pop After Securing $100M Of FinancingNASDAQ:SCLXScilex Holding Company
      06/11/20247:20PMGlobeNewswire Inc.Scilex Holding Company Announces 5-Year Term of $100 Million Financing with Royalty-Based Payments and Potential Strategic Transactions with Perigrove and its Portfolio CompaniesNASDAQ:SCLXScilex Holding Company
      06/11/20249:00AMGlobeNewswire Inc.Scilex Holding Company Announces That Many National Pharmacy Chains and Independent Pharmacies Have Begun Stocking GLOPERBA®NASDAQ:SCLXScilex Holding Company
      06/10/202411:49AMGlobeNewswire Inc.Scilex Holding Company Announces Stocking of GLOPERBA® is Underway in all of the Wholesalers with which Scilex has Stocking Arrangements Throughout the U.S.NASDAQ:SCLXScilex Holding Company
      06/06/20242:56PMGlobeNewswire Inc.Scilex Holding Company announces the U.S. FDA has approved the sNDA for commercial manufacturing of Gloperba® which will be launched in the US in the week of June 10th 2024NASDAQ:SCLXScilex Holding Company
      05/30/20241:19PMGlobeNewswire Inc.Scilex Holding Company Sends Letters to the U.S. Securities and Exchange Commission and Financial Industry Regulatory Authority Regarding Illegal Market Manipulation of the Common Stock of Scilex Holding CompanyNASDAQ:SCLXScilex Holding Company
      05/24/20241:40PMGlobeNewswire Inc.Scilex Holding Company Announces it has been Added to the MSCI Global Microcap IndexNASDAQ:SCLXScilex Holding Company
      05/24/20249:00AMGlobeNewswire Inc.Scilex Holding Company Sends Letter to U.S. House of Representatives on Illegal Market Manipulation of the Common Stock of Scilex Holding CompanyNASDAQ:SCLXScilex Holding Company
      05/14/20249:00AMGlobeNewswire Inc.Scilex Holding Company Announces Final Court Approval of a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s intent to Expand the Label for its FDA-Approved Liquid Colchicine ProNASDAQ:SCLXScilex Holding Company
      05/13/20249:00AMGlobeNewswire Inc.Scilex Holding Company Provides Information to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common StockNASDAQ:SCLXScilex Holding Company
      04/25/20244:01PMGlobeNewswire Inc.Scilex Holding Company Announces Closing of $15 Million Registered Direct OfferingNASDAQ:SCLXScilex Holding Company
      04/24/20248:00AMGlobeNewswire Inc.Scilex Holding Company Announces $15 Million Registered Direct OfferingNASDAQ:SCLXScilex Holding Company
      04/16/20249:00AMGlobeNewswire Inc.Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross and Net Sales for ZTlido® for the First Quarter 2024; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other AdNASDAQ:SCLXScilex Holding Company
      04/09/20249:00AMGlobeNewswire Inc.Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido® and ELYXYB® for Commercially Insured Patients and the addition of ELYXYB® to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing PoolNASDAQ:SCLXScilex Holding Company
      03/27/20249:00AMGlobeNewswire Inc.Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a DividendNASDAQ:SCLXScilex Holding Company
      03/21/20249:30AMGlobeNewswire Inc.Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured PatientsNASDAQ:SCLXScilex Holding Company
      03/20/202411:00AMGlobeNewswire Inc.Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is NeededNASDAQ:SCLXScilex Holding Company
      03/20/20249:00AMGlobeNewswire Inc.Scilex Holding Company Announces a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s Filing of a sNDA with the FDA Seeking to Expand the Label for its FDA-Approved Liquid ColchicNASDAQ:SCLXScilex Holding Company
      03/19/20249:00AMGlobeNewswire Inc.Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and InnovationNASDAQ:SCLXScilex Holding Company
      03/18/20249:00AMGlobeNewswire Inc.Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura inNASDAQ:SCLXScilex Holding Company
      03/15/20242:45PMGlobeNewswire Inc.Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc.NASDAQ:SCLXScilex Holding Company
      03/15/20249:00AMGlobeNewswire Inc.Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of SNASDAQ:SCLXScilex Holding Company
      03/11/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SCLXScilex Holding Company
      03/05/20244:22PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SCLXScilex Holding Company
      03/05/20244:20PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
      03/05/20244:17PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
      03/05/20244:16PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
      03/05/20244:13PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
       Showing the most relevant articles for your search:NASDAQ:SCLX

      Your Recent History

      NASDAQ
      ABAMBXX
      Morgan Stanley Finance L...
      Delayed Upgrade Clock